封面
市场调查报告书
商品编码
1386254

女性健康疾病诊断与治疗市场报告:到2030年的趋势、预测与竞争分析

Women Health Disease Diagnosis & Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

女性健康疾病诊治趋势及预测

预计到2030年,全球女性健康疾病诊断与治疗市场预计将达到281.9亿美元,2024年至2030年年复合成长率为6.5%。该市场的主要驱动因素是女性健康疾病发病率的上升、女性医疗保健意识的提高以及越来越多地采用现场护理和快速诊断测试。全球女性健康疾病诊断与治疗市场前景广阔,医院、诊所和诊断中心市场充满商机。

女性健康疾病诊治市场洞察

Lucintel 预测,癌症预计将在预测期内经历最高的增长。

医院仍然是该市场中最大的部分。

由于该地区医疗基础设施的不断改善、对妇女健康疾病的认识不断提高以及 POC 诊断的采用率不断提高,预计亚太地区将在预测期内实现最高的增长。

本报告回答了 11 个关键问题:

  • Q.1. 细分市场中最有前途和高成长的机会是什么?
  • Q.2.哪个细分市场将以更快的速度成长?为什么?
  • Q.3.您认为哪些地区未来会出现更快的成长?为什么?
  • Q.4. 影响市场动态的主要因素有哪些?市场的主要挑战和商业风险是什么?
  • Q.5. 这个市场的商业风险和竞争威胁是什么?
  • Q.6.这个市场有哪些新趋势?为什么?
  • Q.7.市场客户需求有何改变?
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位?
  • Q.9.这个市场的主要企业有哪些?主要企业采取哪些策略配合措施来发展业务?
  • Q.10. 该市场上的竞争产品有哪些?由于材料或产品替代而导致市场占有率下降的威胁有多大?
  • Q.11.过去年度发生了哪些併购事件,对产业产生了哪些影响?

目录

第1章执行摘要

第2章全球女性健康疾病诊疗市场:市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势(2018-2023)与预测(2024-2030)
  • 全球女性健康疾病诊断与治疗市场趋势(2018-2023)与预测(2024-2030)
  • 按类型分類的全球女性健康疾病诊断与治疗市场
    • 尿道感染及其病症
    • 产前生殖健康
    • 闭经
    • 癌症
    • 骨质疏鬆症
  • 全球女性健康疾病诊断与治疗市场(按最终用途)
    • 医院
    • 诊所
    • 诊断中心
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球女性健康疾病诊断与治疗市场区域分布
  • 北美女性健康疾病诊疗市场
  • 欧洲女性健康疾病诊治市场
  • 亚太女性健康疾病诊断与治疗市场
  • 其他地区女性健康疾病诊疗市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球女性健康疾病诊断与治疗市场成长机会(按类型)
    • 全球女性健康疾病诊断与治疗市场成长机会(以最终用途)
    • 全球女性健康疾病诊断与治疗市场按地区成长机会
  • 全球女性健康疾病诊疗市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球女性健康诊断和治疗市场的能力
    • 全球女性健康诊断和治疗市场的合併和收购
    • 认证和许可

第7章主要企业概况

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories
简介目录

Women Health Disease Diagnosis & Treatment Trends and Forecast

The future of the global women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets. The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

A more than 150-page report is developed to help in your business decisions.

Women Health Disease Diagnosis & Treatment by Segment

The study includes a forecast for the global women health disease diagnosis & treatment by type, end use, and region.

Women Health Disease Diagnosis & Treatment Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Urinary Tract Infection and Condition
  • Prenatal Reproductive Health
  • Menopause
  • Cancer
  • Osteoporosis

Women Health Disease Diagnosis & Treatment Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

Women Health Disease Diagnosis & Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Women Health Disease Diagnosis & Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies women health disease diagnosis & treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the women health disease diagnosis & treatment companies profiled in this report include-

  • General Electric
  • Coopersurgical
  • Ascend Therapeutics
  • Rinovum Women'S Health
  • Quest Diagnostics Incorporated
  • Hologic
  • Perkinelmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Women Health Disease Diagnosis & Treatment Market Insights

Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Within this market, hospitals will remain the largest segment.

APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Features of the Global Women Health Disease Diagnosis & Treatment Market

Market Size Estimates: Women Health Disease Diagnosis & Treatment Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Women Health Disease Diagnosis & Treatment Market size by type, end use, and region in terms of value ($B).

Regional Analysis: Women Health Disease Diagnosis & Treatment Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the women health disease diagnosis & treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the women health disease diagnosis & treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the women health disease diagnosis & treatment market size?

Answer: The global women health disease diagnosis & treatment market is expected to reach an estimated $28.19 billion by 2030.

Q.2 What is the growth forecast for women health disease diagnosis & treatment market?

Answer: The global women health disease diagnosis & treatment market is expected to grow with a cagr of 6.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the women health disease diagnosis & treatment market?

Answer: The major drivers for this market are risng number of women health disorders, growing awareness concerning women healthcare, and increasing adoption of point-of-care and rapid diagnostic tests.

Q4. What are the major segments for women health disease diagnosis & treatment market?

Answer: The future of the women health disease diagnosis & treatment market looks promising with opportunities in the hospital, clinic, and diagnostic center markets.

Q5. Who are the key women health disease diagnosis & treatment market companies?

Answer: Some of the key women health disease diagnosis & treatment companies are as follows:

  • General Electric
  • CooperSurgical
  • ASCEND Therapeutics
  • Rinovum Women's Health
  • Quest Diagnostics Incorporated
  • Hologic
  • PerkinElmer
  • Cardinal Health
  • Becton and Dickinson
  • Abbott Laboratories

Q6. Which women health disease diagnosis & treatment market segment will be the largest in future?

Answer: Lucintel forecasts that cancer is expected to witness highest growth over the forecast period.

Q7. In women health disease diagnosis & treatment market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to on-going improvement of healthcare infrastructure, growing awareness towards women's health disorders, and rising adoption of POC diagnostics in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the women health disease diagnosis & treatment market by type (urinary tract infection and condition, prenatal reproductive health, menopause, cancer, and osteoporosis), end use (hospitals, clinics, diagnostic centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Women Health Disease Diagnosis & Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Women Health Disease Diagnosis & Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Women Health Disease Diagnosis & Treatment Market by Type
    • 3.3.1: Urinary Tract Infection and Condition
    • 3.3.2: Prenatal Reproductive Health
    • 3.3.3: Menopause
    • 3.3.4: Cancer
    • 3.3.5: Osteoporosis
  • 3.4: Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 3.4.1: Hospitals
    • 3.4.2: Clinics
    • 3.4.3: Diagnostic Centers
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Women Health Disease Diagnosis & Treatment Market by Region
  • 4.2: North American Women Health Disease Diagnosis & Treatment Market
    • 4.2.2: North American Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.3: European Women Health Disease Diagnosis & Treatment Market
    • 4.3.1: European Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.3.2: European Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.4: APAC Women Health Disease Diagnosis & Treatment Market
    • 4.4.1: APAC Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.4.2: APAC Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others
  • 4.5: ROW Women Health Disease Diagnosis & Treatment Market
    • 4.5.1: ROW Women Health Disease Diagnosis & Treatment Market by Type: Urinary Tract Infection and Condition, Prenatal Reproductive Health, Menopause, Cancer, and Osteoporosis
    • 4.5.2: ROW Women Health Disease Diagnosis & Treatment Market by End Use: Hospitals, Clinics, Diagnostic Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Type
    • 6.1.2: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by End Use
    • 6.1.3: Growth Opportunities for the Global Women Health Disease Diagnosis & Treatment Market by Region
  • 6.2: Emerging Trends in the Global Women Health Disease Diagnosis & Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Women Health Disease Diagnosis & Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: General Electric
  • 7.2: CooperSurgical
  • 7.3: ASCEND Therapeutics
  • 7.4: Rinovum Women's Health
  • 7.5: Quest Diagnostics Incorporated
  • 7.6: Hologic
  • 7.7: PerkinElmer
  • 7.8: Cardinal Health
  • 7.9: Becton and Dickinson
  • 7.10: Abbott Laboratories